The purpose of this requirement is to acquire and stockpile 277,632 pkgs of relenza (zanamivir) rotadisk, 5MG, NDC 00173-0681-22, over a 12-month period.
Ended Awarded Last action
- Contract number
- 75A50322F80027
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $7,287,840
Award facts
- Opportunity
-
- 75A50322Q00027 Solicitation number
- Contract value 100% obligated
- $7,287,840.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- Q517 Pharmacy Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Fixed Price Award Fee
- Place of performance
- Washington, DC 20201, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $7,287,840 |
About this award
This federal contract award to Glaxosmithkline, LLC, doing business as Glaxosmithkline, is for the acquisition and stockpiling of 277,632 packages of the antiviral medication Relenza (zanamivir) over a 12-month period. The $7,287,840.00 fixed-price delivery order was issued by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency within the U.S. Department of Health and Human Services. The contract supports disease prevention and preparedness efforts, with no set-aside designation. Glaxosmithkline has provided a range of pharmaceutical products, including vaccines and antivirals, to various federal agencies through both contracts and grant subawards. The company holds multiple award indefinite delivery vehicles with the Department of Veterans Affairs, Centers for Disease Control and Prevention, and Defense Logistics Agency for the supply of seasonal influenza vaccines, vaccine storage and rotation services, and the antiviral medication zanamivir.
Quick answers
Who was awarded contract 75A50322F80027?
75A50322F80027 was awarded to Glaxosmithkline, LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 26, 2022.
How much is contract 75A50322F80027 worth?
The government has obligated $7,287,840 on 75A50322F80027.
Is contract 75A50322F80027 an order under another contract?
Yes. 75A50322F80027 is a delivery order under 36F79722D0178, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 75A50322F80027 competed?
The extent of competition for 75A50322F80027 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award